Sampre Nutritions Ltd
Sampre Nutritions Ltd maintains a debt-to-equity ratio of 0.78, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a current ratio of 1.31, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints. In terms of profitability, the company's return on equity (ROE) is 2.1%, and its return on assets (ROA) is 1.05%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating robust returns relative to its equity and asset base. The company's operating income of INR 11.2 million and net income of INR 4.7 million suggest a narrow profit margin, which may be a concern in a competitive industry. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher operational an
Business. Sampre Nutritions Ltd (SAMN.BO) is an Indian food processing company operating within the Consumer Non-Cyclicals sector. The firm is primarily engaged in the production and sale of food products, generating revenue through its product-sale business model. Headquartered in India, the company is listed on the Bombay Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Sampre Nutritions Ltd (SAMN.BO) is an Indian food processing company operating within the Consumer Non-Cyclicals sector. The firm is primarily engaged in the production and sale of food products, generating revenue through its product-sale business model. Headquartered in India, the company is listed on the Bombay Stock Exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.
Sampre Nutritions Ltd maintains a debt-to-equity ratio of 0.78, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is characterized as medium, with a current ratio of 1.31, suggesting it has sufficient short-term assets to cover its short-term liabilities, but with limited excess. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity constraints.
In terms of profitability, the company's return on equity (ROE) is 2.1%, and its return on assets (ROA) is 1.05%. These figures are below the typical thresholds for strong performance in the food processing industry, indicating that the company is not generating robust returns relative to its equity and asset base. The company's operating income of INR 11.2 million and net income of INR 4.7 million suggest a narrow profit margin, which may be a concern in a competitive industry.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to higher operational and market risks if demand in its primary market fluctuates.
Looking ahead, the company's growth trajectory is uncertain. The available data does not provide specific revenue growth projections for the current or next fiscal year. However, the company's capital expenditure of INR -37.09 million indicates a reduction in investment in new assets, which may signal a conservative approach to growth or a focus on cost management.
The company's risk profile includes medium liquidity risk and low dilution risk. The negative net cash position after debt is a key liquidity flag, and while the company has not indicated plans for significant equity dilution, the potential for future dilution remains low. The company's financial structure and operating cash flow of INR 39.52 million suggest it has the capacity to meet its short-term obligations, but long-term debt of INR 175.00 million could pose a challenge if interest rates rise or if cash flow is disrupted.
Recent events and filings do not indicate any major corporate actions or strategic shifts. The company's latest financial statements and disclosures do not highlight any significant legal, regulatory, or operational risks that would impact its near-term performance.
- Sampre Nutritions Ltd has a moderate debt-to-equity ratio of 0.78, indicating a balanced capital structure.
- The company's ROE of 2.1% and ROA of 1.05% are below industry norms, suggesting suboptimal returns on equity and assets.
- The company's liquidity position is medium, with a current ratio of 1.31 and a negative net cash position after debt.
- Sampre Nutritions Ltd has not disclosed geographic or segment diversification, which could increase its exposure to market-specific risks.
- The company's capital expenditure is negative, indicating a reduction in investment, which may affect long-term growth.
- The company's risk profile is characterized by medium liquidity risk and low dilution risk.
Bull / Bear case
Generated · model-assistedCash conversion ratio of 8.38 is best-in-class, significantly outperforming the cohort median of 0.98.
Revenue CAGR of 8.3% over four years suggests moderate top-line growth despite recent volatility.
Dilution risk is assessed as low, providing some protection to existing shareholders from equity erosion.
High credit risk and medium liquidity risk flags suggest potential difficulties in meeting financial obligations.
In focus — financials by report
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Sampre Nutritions Ltd Market data — financials · 2026-05-29